Results 21 to 30 of about 89,416 (210)

Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments

open access: yesBMC Psychiatry, 2022
Background Antipsychotic drugs are associated with adverse events, but serious side effects are not frequent. This study aimed to ascertain whether previous exposure to antipsychotic treatment was associated with metabolic disturbances induced by current
Ye Yang   +7 more
doaj   +1 more source

Antipsychotic Polypharmacy and High-Dose Antipsychotic Regimens in the Residential Italian Forensic Psychiatric Population (REMS)

open access: yesFrontiers in Psychology, 2022
Few data exist regarding treatment with antipsychotics in forensic psychiatric patient populations with high social dangerousness. We performed a secondary analysis of 681 patients treated with at least one antipsychotic, extracted from a 1-year ...
Gabriele Mandarelli   +3 more
doaj   +1 more source

Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database [PDF]

open access: yes, 2013
Background: Drug-induced torsades de pointes (TdP) and related clinical entities represent a current regulatory and clinical burden. Objective: As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US ...
MORETTI, Ugo   +37 more
core   +1 more source

Drug utilization study of antipsychotic drugs in the psychiatry outpatient department of a tertiary care hospital

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2019
Background: Prescribing pattern of antipsychotics has changed over the decade with availability of newer antipsychotics. Aims and Objectives: This study aims to analyze the utilization pattern of antipsychotics at our hospital.
Aashal Shah   +3 more
doaj   +1 more source

Prescriptions of Antipsychotics in Younger and Older Geriatric Patients with Polypharmacy, Their Safety, and the Impact of a Pharmaceutical-Medical Dialogue on Antipsychotic Use

open access: yesBiomedicines, 2022
Geriatric patients are a particularly vulnerable and, at the same time, very heterogeneous group due to their multimorbidity and polypharmacy. Antipsychotics are often prescribed in their complex drug regimens, whereby the prescription of antipsychotics ...
Eva-Maria Gebauer, Albert Lukas
doaj   +1 more source

Risk of dyslipidaemia with antipsychotic drug treatment in Chinese inpatients with mental illness: a hospital-based cohort study

open access: yesBMJ Open, 2021
Objectives To determine the association of long-term use of antipsychotics with the risk of dyslipidaemia.Design A hospital-based cohort study.Setting Electronic health record data of adult mental health inpatients in all 19 specialised psychiatric ...
Juan Li   +8 more
doaj   +1 more source

Associations between antipsychotics and the risk of incident cardiovascular diseases in individuals with schizophrenia: a nested case–control study

open access: yesBMJ Mental Health, 2023
Background The association between antipsychotics and cardiovascular diseases (CVDs) remains significant yet unestablished, especially in Chinese populations.Objective To investigate the risk of CVDs associated with antipsychotics among Chinese ...
Peng Peng   +7 more
doaj   +1 more source

Second-generation antipsychotics and seizures - a systematic review and meta-analysis of serious adverse events in randomized controlled trials. [PDF]

open access: yes, 2023
Seizures are suspected to be side effects of antipsychotics. To examine a possible causal relationship, we compared the risk of seizures on second-generation antipsychotics to the risk on placebo in randomized controlled clinical trials (RCTs) across ...
Efthimiou, Orestis   +3 more
core   +1 more source

Adherence to typical antipsychotics

open access: yes, 2022
 There has been a recent transition from typical to atypical antipsychotics in the management of schizophrenia. This has been attributed to the acute side effects experienced by patients on typical antipsychotics that lead to non-adherence.
Mark Mohan Kaggwa (10733064)
core   +2 more sources

Serum paraoxonase levels of schizophrenia patients treated with typical, atypical and combined antipsychotics

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: Schizophrenia is a devastating disorder, starting in early adulthood and continuing with relapses and remissions. Prevalence of schizophrenia is 1% and the life expectancy of these patients is reduced.
Mehmet Akif Camkurt   +6 more
doaj  

Home - About - Disclaimer - Privacy